Kriti Nutrients Q4 EBITDA Jumps YoY; FY26 Audited Results Published in Press
Kriti Nutrients Limited reported Q4 FY26 standalone net profit of ₹619.05 lakhs (up from ₹494.93 lakhs YoY) and full-year total income from operations of ₹92,948.36 lakhs (vs ₹74,210.06 lakhs). Q4 EBITDA improved to 93M rupees with a margin of 3.65%, while the board declared no final dividend, having already paid an interim dividend of ₹3/- per share. Results were published in Chautha Sansar and Business Standard on 7 May 2026.

*this image is generated using AI for illustrative purposes only.
Kriti Nutrients Limited's Board of Directors, at its meeting held on 5 May 2026, approved the standalone and consolidated audited financial results for the quarter and year ended 31 March 2026. The results were subsequently published in Chautha Sansar and Business Standard on 7 May 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board also decided not to recommend any final dividend on equity shares of Re 1/- each for the financial year 2025-26, noting that an interim dividend of ₹3/- per share had already been declared and paid.
Quarterly Performance
Kriti Nutrients delivered a notable improvement in quarterly profitability and operating performance on a year-on-year basis. Q4 EBITDA rose to 93M rupees from 60.9M rupees in the year-ago quarter, while the EBITDA margin improved to 3.65% from 3.04% over the same period. Standalone revenue from operations for the quarter stood at ₹25,523.21 lakhs, compared to ₹20,005.31 lakhs in the corresponding quarter of the previous year and ₹22,430.73 lakhs in the preceding quarter ended 31 December 2025. Standalone net profit for the quarter rose to ₹619.05 lakhs from ₹494.93 lakhs in Q4 FY25. On a consolidated basis, net profit for the quarter was ₹636.06 lakhs, compared to ₹491.89 lakhs in the year-ago quarter.
| Metric: | Q4 FY26 (Standalone) | Q3 FY26 (Standalone) | Q4 FY25 (Standalone) |
|---|---|---|---|
| Revenue from Operations (₹ Lakhs): | 25,523.21 | 22,430.73 | 20,005.31 |
| Total Revenue (₹ Lakhs): | 25,683.07 | 22,621.36 | 20,198.61 |
| Profit Before Tax (₹ Lakhs): | 928.09 | 1,185.39 | 644.21 |
| Net Profit After Tax (₹ Lakhs): | 619.05 | 921.27 | 494.93 |
| EBITDA (M Rupees): | 93 | — | 60.9 |
| EBITDA Margin (%): | 3.65 | — | 3.04 |
Financial Performance: Revenue and Profitability
Kriti Nutrients reported strong revenue growth for the full year, with standalone total income from operations rising to ₹92,948.36 lakhs from ₹74,210.06 lakhs in the previous year. Net profit after tax for the year on a standalone basis stood at ₹3,384.05 lakhs, compared to ₹3,702.38 lakhs in the prior year. The consolidated net profit for the year, inclusive of the share in associate's profit, stood at ₹3,390.13 lakhs compared to ₹3,699.35 lakhs previously. The equity share capital remained unchanged at ₹501.04 lakhs (face value of ₹1/- each). The following table presents the key standalone and consolidated financial highlights:
| Metric: | Standalone FY26 | Standalone FY25 | Consolidated FY26 | Consolidated FY25 |
|---|---|---|---|---|
| Total Income from Operations (₹ Lakhs): | 92,948.36 | 74,210.06 | 92,948.36 | 74,210.06 |
| Profit Before Tax (₹ Lakhs): | 4,511.03 | 4,977.63 | 4,511.03 | 4,977.63 |
| Net Profit After Tax (₹ Lakhs): | 3,384.05 | 3,702.38 | 3,390.13 | 3,699.35 |
| Total Comprehensive Income (₹ Lakhs): | 3,370.99 | 3,690.66 | 3,380.02 | 3,687.57 |
| Reserves (excl. Revenue Reserve) (₹ Lakhs): | 22,405.59 | 20,688.02 | 22,411.53 | 20,684.93 |
| Equity Share Capital (₹ Lakhs): | 501.04 | 501.04 | 501.04 | 501.04 |
| Basic EPS (₹): | 6.75 | 7.39 | 6.77 | 7.38 |
| Diluted EPS (₹): | 6.75 | 7.39 | 6.77 | 7.38 |
Balance Sheet Highlights
As at 31 March 2026, standalone total assets stood at ₹27,266.27 lakhs, up from ₹23,782.93 lakhs as at 31 March 2025. Total equity increased to ₹22,906.63 lakhs from ₹21,189.06 lakhs. Cash and cash equivalents rose significantly to ₹4,625.45 lakhs from ₹170.78 lakhs. On the consolidated basis, total assets were ₹27,272.20 lakhs and total equity was ₹22,912.56 lakhs.
| Parameter: | Standalone 31.03.2026 | Standalone 31.03.2025 | Consolidated 31.03.2026 | Consolidated 31.03.2025 |
|---|---|---|---|---|
| Total Assets (₹ Lakhs): | 27,266.27 | 23,782.93 | 27,272.20 | 23,779.83 |
| Total Equity (₹ Lakhs): | 22,906.63 | 21,189.06 | 22,912.56 | 21,185.97 |
| Cash & Cash Equivalents (₹ Lakhs): | 4,625.45 | 170.78 | 4,625.45 | 170.78 |
| Total Non-Current Assets (₹ Lakhs): | 13,534.37 | 14,260.45 | 13,540.30 | 14,257.35 |
| Total Current Assets (₹ Lakhs): | 13,731.90 | 9,522.48 | 13,731.90 | 9,522.48 |
| Total Non-Current Liabilities (₹ Lakhs): | 645.88 | 653.52 | 645.88 | 653.51 |
| Total Current Liabilities (₹ Lakhs): | 3,713.76 | 1,940.36 | 3,713.76 | 1,940.35 |
Cash Flow Summary
Net cash from operating activities for the year stood at ₹6,428.73 lakhs on both a standalone and consolidated basis, compared to ₹3,195.79 lakhs in the previous year. Net cash used in investing activities was ₹934.98 lakhs, while net cash used in financing activities was ₹1,039.08 lakhs. The net increase in cash and cash equivalents for the year was ₹4,454.67 lakhs, with closing cash and cash equivalents of ₹4,625.45 lakhs against an opening balance of ₹170.78 lakhs.
Board Decisions: Dividend and Leadership
The board confirmed that no final dividend is recommended for FY2025-26, as an interim dividend of ₹3/- per share had already been declared at the board meeting held on 8 November 2025 and paid on 15 November 2025. On leadership matters, the board approved, subject to member approval at the General Meeting, the re-appointment of Mr. Shiv Singh Mehta (DIN: 00023523) as Chairman and Managing Director for a period of three years with effect from 12 January 2027. The board also approved the re-designation of Mr. Saurabh Singh Mehta (DIN: 00023591) as Joint Managing Director for the remaining period from 5 May 2026 to 31 July 2027, and his subsequent re-appointment as Whole-time Director designated as Joint Managing Director for a period of three years with effect from 1 August 2027, both subject to member approval.
| Board Decision: | Details |
|---|---|
| Final Dividend Recommended: | None |
| Interim Dividend (Already Paid): | ₹3/- per share |
| CMD Re-appointment: | Mr. Shiv Singh Mehta, 3 years w.e.f. 12 Jan 2027 |
| JMD Re-designation: | Mr. Saurabh Singh Mehta, 5 May 2026 to 31 Jul 2027 |
| JMD Re-appointment: | Mr. Saurabh Singh Mehta, 3 years w.e.f. 1 Aug 2027 |
| Auditor Opinion: | Unmodified |
Regulatory and Audit Disclosures
The financial results were reviewed by the Audit Committee at its meeting held on 4 May 2026 and subsequently taken on record by the Board of Directors on 5 May 2026. The statutory auditors, M Mehta & Company, Chartered Accountants (Firm Registration No. 000957C), expressed an unmodified audit opinion on both the standalone and consolidated financial results. The company operates in a single business segment — Oil Seed Extraction and Refining — as per Ind AS 108. The consolidated financial statements include the results of associate company Kriti Industries (India) Limited, in which Kriti Nutrients holds 6.24% of share capital and exercises significant influence. The disclosure was filed with both the National Stock Exchange of India Limited and BSE Limited, and was signed by Raj Kumar Bhawsar, Company Secretary and Compliance Officer.
Source: None/Company/INE798K01010/c59aa163-7596-4186-8baf-ab93c40b9474.pdf
Historical Stock Returns for Kriti Nutrients
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.59% | -7.23% | +42.80% | +3.83% | -7.83% | +67.69% |


































